Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$119.89
0.300.25%
À la fermeture: -
$120.00
0.110.09%
Après les heures de négociation: 6:05 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Clorox Co a un objectif de cours consensus de $138.56, basé sur les évaluations des 20 analystes. Le plus élevé est de $170 attribué par TD Cowen le novembre 6, 2024, et le plus bas est de $112 attribué par Barclays le octobre 1, 2025. Les 3 dernières évaluations d'analystes ont été publiées par JP Morgan, Citigroup et B of A Securities le octobre 10, 2025, octobre 9, 2025 et octobre 8, 2025. Avec un objectif de cours moyen de $127.33 entre JP Morgan, Citigroup et B of A Securities, il y a une variation implicite de 6.11% upside pour Clorox Co à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
JP Morgan
Citigroup
B of A Securities
UBS
Barclays
1calculé à partir des notes des analystes
Notes d'analystes pour Clorox
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/10/2025 | 5.83% | JP Morgan | $135 → $127 | Maintains | Neutral | |||
10/09/2025 | 8.33% | Citigroup | $135 → $130 | Maintains | Neutral | |||
10/08/2025 | 4.17% | B of A Securities | $135 → $125 | Maintains | Neutral | |||
10/08/2025 | 6.67% | UBS | $134 → $128 | Maintains | Neutral | |||
10/01/2025 | -6.67% | Barclays | $118 → $112 | Maintains | Underweight | |||
09/25/2025 | 4.17% | Wells Fargo | $130 → $125 | Maintains | Equal-Weight | |||
09/08/2025 | 12.5% | JP Morgan | $133 → $135 | Maintains | Neutral | |||
09/05/2025 | 8.33% | Wells Fargo | $138 → $130 | Maintains | Equal-Weight | |||
08/01/2025 | 14.17% | Morgan Stanley | $150 → $137 | Maintains | Equal-Weight | |||
08/01/2025 | 15% | Wells Fargo | $135 → $138 | Maintains | Equal-Weight | |||
07/25/2025 | 16.67% | JP Morgan | $144 → $140 | Maintains | Neutral | |||
07/17/2025 | 11.67% | UBS | $150 → $134 | Maintains | Neutral | |||
07/15/2025 | 12.5% | Citigroup | $140 → $135 | Maintains | Neutral | |||
07/15/2025 | -0.83% | Barclays | $129 → $119 | Maintains | Underweight | |||
07/09/2025 | 12.5% | Wells Fargo | $142 → $135 | Maintains | Equal-Weight | |||
06/26/2025 | 20.83% | Jefferies | $167 → $145 | Maintains | Buy | |||
05/07/2025 | 7.5% | Barclays | $134 → $129 | Maintains | Underweight | |||
05/06/2025 | 25% | Morgan Stanley | $165 → $150 | Maintains | Equal-Weight | |||
05/06/2025 | 18.33% | Wells Fargo | $145 → $142 | Maintains | Equal-Weight | |||
05/06/2025 | 20% | JP Morgan | $151 → $144 | Maintains | Neutral | |||
04/17/2025 | 28.33% | UBS | $176 → $154 | Maintains | Neutral | |||
04/16/2025 | 20.83% | Wells Fargo | $155 → $145 | Maintains | Equal-Weight | |||
04/14/2025 | 25% | Citigroup | $165 → $150 | Maintains | Neutral | |||
04/11/2025 | 11.67% | Barclays | $139 → $134 | Maintains | Underweight | |||
04/11/2025 | 25.83% | JP Morgan | $173 → $151 | Maintains | Neutral | |||
04/02/2025 | 29.17% | Wells Fargo | $161 → $155 | Maintains | Equal-Weight | |||
03/27/2025 | 15.83% | Barclays | $140 → $139 | Maintains | Underweight | |||
02/05/2025 | 16.67% | Barclays | $130 → $140 | Maintains | Underweight | |||
02/05/2025 | 40.83% | DA Davidson | $171 → $169 | Maintains | Neutral | |||
02/04/2025 | 44.17% | JP Morgan | $171 → $173 | Maintains | Neutral | |||
02/04/2025 | 34.17% | Wells Fargo | $157 → $161 | Maintains | Equal-Weight | |||
01/30/2025 | 25% | RBC Capital | $150 → $150 | Reiterates | Sector Perform → Sector Perform | |||
01/17/2025 | 8.33% | Barclays | $139 → $130 | Maintains | Underweight | |||
01/16/2025 | 42.5% | JP Morgan | $167 → $171 | Maintains | Neutral | |||
01/07/2025 | 30.83% | Wells Fargo | $155 → $157 | Upgrade | Underweight → Equal-Weight | |||
11/06/2024 | 41.67% | TD Cowen | $155 → $170 | Upgrade | Sell → Hold | |||
11/04/2024 | 42.5% | DA Davidson | $153 → $171 | Maintains | Neutral | |||
11/01/2024 | 15.83% | Barclays | $137 → $139 | Maintains | Underweight | |||
10/14/2024 | 15.83% | Evercore ISI Group | $140 → $139 | Maintains | Underperform | |||
10/11/2024 | 14.17% | Barclays | $130 → $137 | Maintains | Underweight | |||
10/11/2024 | 45% | JP Morgan | $148 → $174 | Maintains | Neutral | |||
10/01/2024 | 55.83% | Jefferies | $174 → $187 | Upgrade | Hold → Buy | |||
09/06/2024 | 41.67% | Citigroup | $165 → $170 | Maintains | Neutral | |||
09/06/2024 | 27.5% | DA Davidson | $153 → $153 | Maintains | Neutral | |||
08/28/2024 | 37.5% | Citigroup | $145 → $165 | Maintains | Neutral | |||
08/05/2024 | 8.33% | Barclays | $122 → $130 | Maintains | Underweight | |||
08/02/2024 | 27.5% | DA Davidson | $162 → $153 | Maintains | Neutral | |||
08/02/2024 | 23.33% | JP Morgan | $150 → $148 | Maintains | Neutral | |||
08/02/2024 | 25.83% | Deutsche Bank | $144 → $151 | Maintains | Hold | |||
07/23/2024 | 1.67% | TD Cowen | → $122 | Initiates | → Sell | |||
07/22/2024 | 25% | JP Morgan | $158 → $150 | Maintains | Neutral | |||
07/19/2024 | 1.67% | Barclays | $132 → $122 | Maintains | Underweight | |||
07/10/2024 | 20.83% | Citigroup | $150 → $145 | Maintains | Neutral | |||
07/10/2024 | 8.33% | Wells Fargo | $135 → $130 | Maintains | Underweight | |||
06/24/2024 | 8.33% | Exane BNP Paribas | → $130 | Initiates | → Underperform | |||
05/02/2024 | 12.5% | Wells Fargo | $140 → $135 | Maintains | Underweight | |||
05/02/2024 | 10% | Barclays | $136 → $132 | Maintains | Underweight | |||
05/01/2024 | 25% | Citigroup | $155 → $150 | Maintains | Neutral | |||
05/01/2024 | 32.5% | UBS | $164 → $159 | Maintains | Neutral | |||
05/01/2024 | 31.67% | JP Morgan | $159 → $158 | Maintains | Neutral | |||
05/01/2024 | 18.33% | Evercore ISI Group | $145 → $142 | Maintains | Underperform | |||
04/17/2024 | 25.83% | Deutsche Bank | $155 → $151 | Maintains | Hold | |||
04/17/2024 | 35% | DA Davidson | $162 → $162 | Maintains | Neutral | |||
04/16/2024 | 29.17% | Citigroup | $165 → $155 | Maintains | Neutral | |||
04/10/2024 | 13.33% | Barclays | $148 → $136 | Maintains | Underweight | |||
04/02/2024 | 37.5% | Citigroup | $170 → $165 | Downgrade | Buy → Neutral | |||
03/26/2024 | 33.33% | Morgan Stanley | $160 → $160 | Maintains | Equal-Weight | |||
03/26/2024 | 20.83% | Jefferies | → $145 | Upgrade | Underperform → Hold | |||
03/01/2024 | 16.67% | Goldman Sachs | → $140 | Reinstates | → Sell | |||
02/05/2024 | 35% | DA Davidson | → $162 | Downgrade | Buy → Neutral | |||
02/02/2024 | 41.67% | UBS | $145 → $170 | Maintains | Neutral | |||
01/18/2024 | 26.67% | JP Morgan | $145 → $152 | Maintains | Neutral | |||
01/16/2024 | -1.67% | Barclays | $115 → $118 | Maintains | Underweight | |||
12/15/2023 | 25% | B of A Securities | $120 → $150 | Upgrade | Underperform → Neutral | |||
11/22/2023 | 20.83% | JP Morgan | $124 → $145 | Upgrade | Underweight → Neutral | |||
11/17/2023 | 35% | DA Davidson | $152 → $162 | Maintains | Buy | |||
11/13/2023 | -2.5% | Jefferies | → $117 | Initiates | → Underperform | |||
11/06/2023 | 10% | UBS | $124 → $132 | Upgrade | Sell → Neutral | |||
11/02/2023 | 25% | Citigroup | $135 → $150 | Upgrade | Neutral → Buy | |||
10/12/2023 | — | Bernstein | → $120 | Upgrade | Underperform → Market Perform | |||
10/11/2023 | 12.5% | Citigroup | $170 → $135 | Maintains | Neutral | |||
10/05/2023 | — | Evercore ISI Group | $160 → $120 | Maintains | Underperform | |||
10/05/2023 | 3.33% | JP Morgan | $152 → $124 | Maintains | Underweight | |||
10/05/2023 | — | B of A Securities | $145 → $120 | Maintains | Underperform | |||
10/05/2023 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
10/02/2023 | 26.67% | DA Davidson | → $152 | Upgrade | Neutral → Buy | |||
09/22/2023 | 21.67% | HSBC | → $146 | Initiates | → Hold | |||
09/19/2023 | 26.67% | DA Davidson | $176 → $152 | Maintains | Neutral | |||
09/19/2023 | 16.67% | Wells Fargo | $150 → $140 | Maintains | Underweight | |||
08/07/2023 | 46.67% | DA Davidson | $155 → $176 | Maintains | Neutral | |||
08/04/2023 | 5.83% | Barclays | $117 → $127 | Maintains | Underweight | |||
08/03/2023 | — | Atlantic Equities | — | Upgrade | Underweight → Neutral | |||
07/20/2023 | -2.5% | Barclays | $124 → $117 | Maintains | Underweight | |||
07/11/2023 | 41.67% | Citigroup | → $170 | Reiterates | Neutral → Neutral | |||
05/08/2023 | 29.17% | DA Davidson | → $155 | Reiterates | → Neutral | |||
05/04/2023 | 42.5% | Morgan Stanley | $145 → $171 | Maintains | Equal-Weight | |||
05/04/2023 | -1.67% | Barclays | $113 → $118 | Maintains | Underweight | |||
05/03/2023 | 16.67% | B of A Securities | $130 → $140 | Maintains | Underperform | |||
05/03/2023 | 25.83% | RBC Capital | $137 → $151 | Maintains | Sector Perform | |||
05/03/2023 | 25% | Wells Fargo | $145 → $150 | Maintains | Underweight |
FAQ
Quel est le cours indicatif de l'action Clorox (CLX) ?
Le dernier objectif de prix pour Clorox (NYSE:CLX) a été rapporté par JP Morgan le octobre 10, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $127.00 s'attendant à ce que CLX se rise dans les 12 prochains mois (un possible changement de 5.83% upside). 38 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Clorox (CLX) ?
La dernière note d'analyste pour Clorox (NYSE:CLX) a été fournie par JP Morgan, et Clorox maintenu leur note neutral.
Quand a eu lieu la dernière mise à niveau pour Clorox (CLX) ?
La dernière amélioration pour Clorox Co a eu lieu le janvier 7, 2025 lorsque Wells Fargo a augmenté leur objectif de prix à $157. Wells Fargo avait précédemment an underweight pour Clorox Co.
Quand a eu lieu la dernière dégradation pour Clorox (CLX) ?
La dernière réduction pour Clorox Co a eu lieu le avril 2, 2024 lorsque Citigroup a changé leur objectif de prix de $170 à $165 pour Clorox Co.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Clorox (CLX) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Clorox, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Clorox a été déposée le octobre 10, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 10, 2026.
La note d'analyste pour Clorox (CLX) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Clorox (CLX) était un maintenu avec un objectif de prix de $135.00 à $127.00. Le prix actuel de Clorox (CLX) est de $120.00, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.